Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union

European Journal of Gynaecological Oncology

Volumn 26, Issue 5, 2005, Pages 491-498

  Syrjanen S ^a   Shabalova, I ^b,c   Petrovichev, N ^b   Kozachenko, V ^b   Zakharova, T ^b   Pajanidi, J ^b   Podistov, J ^b   Chemeris, G ^b   Sozaeva, L ^c   Lipova, E ^c   Tsidaeva, I ^d   Ivanchenko, O ^d   Pshepurko, A ^d   Zakharenko, S ^e   Nerovjna, R ^f   Kljukina, L ^g   Erokhina, O ^g   Branovskaja, M ^h   Nikitina, M ⁱ   Grunberga, V ⁱ   Grunberg, A ⁱ   Juschenko, A ⁱ   Cintorino, M ^j   Santopietro, R ^j   Tosi, P ^j   Syrjanen K ^j,k   more..

^a UNIVERSITY OF TURKU   (Finland)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c Russian Medical Academy of Post Graduate Education   (Russian Federation)

^d Novgorod Clinical Regional Hospital   (Russian Federation)

^e Novgorod Municipal Dermato venereological Dispensary   (Russian Federation)

^f Novgorod Female Consultative Outpatient Hospital   (Russian Federation)

^g Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

^h BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

ⁱ Latvian Cancer Centre   (Latvia)

^j UNIVERSITY OF SIENA   (Italy)

^k TURKU UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

High risk HPV; Hybrid Capture II; Persistent infection; Predictors; Screening; Virus clearance

Indexed keywords

ADULT; ARTICLE; BIOPSY; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREDICTION; PROSPECTIVE STUDY; REGRESSION ANALYSIS; USSR; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

ADULT; AGE FACTORS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; USSR; UTERINE CERVICAL NEOPLASMS;

EID: 27744521574     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Östor A.G.: "Natural history of cervical intraepithelial neoplasia - a critical review". Int. J. Gynecol. Pathol., 1993, 12, 186.
2. Syrjänen K.: "Natural history of cervical HPV infections and CIN". Chapter 6. In: Syrjänen K. and Syrjänen S.: "Papillomavirus Infections in Human Pathology". New York, J. Wiley & Sons, 2000, 142.
3. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 64. Papillomavirusus. Lyon. IARC, 1995, 1.
4. Syrjänen K., Syrjänen S.: "Papillomavirus Infections in Human Pathology". New York, J. Wiley & Sons, 2000, 1.
5. zur Hausen H.: "Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer". J. Natl. Cancer Inst., 2001, 93, 252.
6. Bosch F.X., Munoz N.: "The viral etiology of cervical cancer". Virus Res., 2002, 89, 183.
7. Aubin F., Pretet J.L., Mougin C. (eds.). Papillomavirus Humains. Biologie et Pathologie Tumorale. Editions TEC & DOC, Paris 2003, 1.
8. Ferenczy A., Franco E.: "Persistent human papillomavirus infection and cervical neoplasia". Lancet Oncol., 2003, 3, 11.
9. Cuzick J., Sasieni P.: "Natural history of cervical human papillomavirus". Lancet, 2001, 358, 1550.
10. Duggan M.A.: "A review of the natural history of cervical intraepithelial neoplasia". Gan To Kagaku Ryoho, 2002, 29 (suppl. 1), 176.
11. Paraskevaidis E., Kaponis A., Malamou-Mitsi V., Davidson E.J., Hirsch P.M., Koliopoulos G.: "The natural history of HPV infection of the uterine cervix. Long-term observational and histological data". Anticancer Res., 2002, 22, 1177.
12. Syrjänen S., Shabalova I.P., Petrovichev N., Kozachenko V.P., Zakharova T., Pajanidi A. et al.: "Acquisition of incident high-risk human papillomavirus (HPV) DNA and Pap smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States (NIS) of the former Soviet Union". J. Clin. Microbiol., 2004, 42, 505.
13. Branca M., Garbuglia A.R., Benedetto A., Cappiello T., Leoncini L., Migliore G. et al.: "Factors predicting the persistence of genital human papillomavirus infections and Pap smear abnormality in HIV-positive and HIV-negative women during prospective follow-up". Int. J. STD AIDS, 2003, 14, 417.
14. Wang S.S., Hildesheim A.: "Viral and host factors in human papillomavirus persistence and progression" Chapter 5. J. Natl. Cancer Inst Monogr., 2003, 31, 35.
15. Franco E.L., Villa L.L., Sobrinho J.P., Prado J.M., Rousseau M.C., Desy M.: "Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer". J. Infect. Dis., 1999, 180, 1415.
16. Giuliano A.R., Harris R., Sedjo R.L., Baldwin S., Roe D., Papenfuss M.R. et al.: "Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study". J. Infect. Dis., 2002, 186, 462.
17. Sellors J.W., Kanvalajtys T.L., Kaczorowski J., Mahony J.B., Lytwyn A., Chong S., Sparrow J., Lorincz A.: "Incidence, clearance and predictors of human papillomavirus infection in women". CMEJ, 2003, 168, 421.
18. Moscicki A.B., Shiboski S., Broering J., Powell K., Clayton L., Jay N. et al.: "The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women". J. Pediatr., 1998, 132, 277.
19. Nobbenhuis M.A., Helmerhorst T.J., van den Brule A.J., Rozendaal L., Voorhorst F.J., Bezemer P.D. et al.: "Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear". Lancet, 2001, 358, 1782.
20. Schiffman M., Wheeler C.M., Castle P.E.: "Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities". J. Infect. Dis., 2002, 186, 1169.
21. Syrjänen S., Shabalova I.P., Petrovichev N., Kozachenko V.P., Zakharova T., Pajanidi A. et al: "Clearance of high-risk human papillomavirus (HPV) DNA and Pap smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States (NIS) of the former Soviet Union". Eur. J. Gynaecol. Obstet. Reprod. Biol., 2005, 119, 219.
22. Cuschieri K.S., Whitley M.J., Cubie H.A.: "Human papillomavirus type specific DNA and RNA persistence-implications for cervical disease progression and monitoring". J. Med. Virol., 2004, 73, 65.
23. Dalstein V., Riethmuller D., Pretet J.L., Le Bail Carval K., Sautiere J.L., Carbillet J.P. et al.: "Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study". Int. J. Cancer, 2003, 106, 396.
24. Kjaer S.K., van den Brule A.J., Paull G., Svare E.I., Sherman M.E., Thomsen B.L. et al.: "Type specific persistence of high-risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study". Br. Med. J., 2002, 325, 572.
25. Wallin K.L., Wiklund F., Angstrom T., Bergman F., Stendahl U., Wadell G. et al.: "Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer". N. Engl. J. Med., 1999, 341, 1633.
26. Giuliano A.R., Siegel E.M., Roe D.J., Ferreira S., Baggio M.L., Galan L. et al.: "Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study". J. Infect. Dis., 2003, 188, 1508.
27. Moscicki A.B., Ellenberg J.H., Farhat S., Xu J.: "Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type". J. Infect. Dis., 2004, 190, 37.
28. Frega A., Stentella P., De Ioris A., Piazze J.J., Fambrini M., Marchionni M. et al.: "Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence". Cancer Lett., 2003, 196, 127.
29. Fife K.H., Katz B.P., Brizendine E.J., Brown D.R.: "Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period". Am. J. Obstet. Gynecol., 1999, 180, 1110.
30. Aho J., Hankins C., Tremblay C., Forest P., Pourreaux K., Rouah F. et al.: "Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women". J. Infect. Dis., 2004, 190, 46.
31. Syrjänen S., Shabalova I.P., Petrovichev N., Kozachenko V.P., Zakharova T., Pajanidi A. et al.: "Human papillomavirus testing and conventional Pap smear cytology as optional screening tools of women at different risk for cervical cancer in countries of former Soviet Union". J. Lower Genital Tract Dis., 2002, 6, 97.
32. Syrjänen S., Shabalova I.P., Petrovichev N., Kozachenko V.P., Zakharova T., Pajanidi A. et al.: "Sexual habits and human papillomavirus (HPV) infections among women in three new independent states of the former Soviet Union". Sex. Transm. Dis., 2003, 30, 680.
33. Syrjänen S., Shabalova I.P., Petrovichev N., Kozachenko V.P., Zakharova T., Pajanidi A. et al.: "Age-specific incidence and clearance rates of high-risk Human Papillomavirus (HPV) infections in women subjected to HPV screening in the new independent states". Int. J. STD. & AIDS, 2005, 16, 217.
34. Miller S.A., Dykes D.D., Polesky H.E: "A simple salting out procedure for extracting DNA from human nucleated cells". Nucleic. Acids Res., 1988, 16, 12.
35. Rintala M., Pöllänen P., Nikkanen V., Grenman S., Syrjänen S.: "Human papillomavirus DNA is found in vas deferens". J. Infect. Dis., 2002, 185, 1664.
36. Kulmala S.-M., Syrjänen S., Shabalova I., Petrovichev N., Kozachenko V., Podistov J. et al.: "The NIS Cohort Study Group. Human papillomavirus testing with hybrid capture 2 assay and PCR as screening tools". J. Clin. Microbiol., 2004, 42, 2470.
37. Vandenvelde C., van Beers D.: "Risk factors inducing the persistence of high risk genital papillomaviruses in the normal cervix". J. Med. Virol., 1992, 38, 226.
38. Brisson J., Bairati I., Morin C., Fortier M., Bouchard C., Christen A. et al.: "Determinants of persistent detection of human papillomavirus DNA in the uterine cervix". J. Infect. Dis., 1996, 173, 794.
39. Ho G.Y., Burk R.D., Klein S., Kadish A.S., Chang C.J., Palan P. et al.: "Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia". J. Natl. Cancer Inst., 1995, 87, 1365.
40. Remmink A.J., Walboomers J.M., Heimerhorst T.J., Voorhorst F.J., Rozendaal L., Risse E.K. et al.: "The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months". Int. J. Cancer, 1995, 61, 306.
41. Acladious N.N., Sutton C., Mandal D., Hopkins R., Zaklama M., Kitchener H.: "Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN)". Int. J. Cancer, 2002, 98, 435.
42. Beby-Defaux A., Bourgoin A., Ragot S., Battandier D., Lemasson J.M., Renaud O. et al.: "Human papillomavirus infection of the cervix uteri in women attending a Health Examination Center of the French social security". J. Med. Virol., 2004, 73, 262.
43. Harris T.G., Kulasingam S.L., Kiviat N.B., Mao C., Agoff S.N., Feng Q. et al.: "Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia". Am. J. Epidemiol., 2004, 159, 834.
44. Minkoff H., Feldman J.G., Strickler H.D., Watts D.H., Bacon M.C., Levine A. et al.: "Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women". J. Infect. Dis., 2004, 189, 1821.
45. Castellsague X., Munoz N. "Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking". Chapter 3. J. Natl. Cancer Inst. Monogr., 2003, 31, 20.
46. Ahdieh L., Klein R.S., Burk R., Cu-Uvin S., Schuman P., Duerr A. et al.: "Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (hiv)-positive and hiv-negative women". J. Infect. Dis., 2001, 184, 682.
47. Giuliano A.R., Papenfuss M., Mendez Brown de Galaz E., Feng J., Abrahamsen M., Denman C. et al.: "Risk factors for squamous intraepithelial lesions (SIL) of the cervix among women residing at the US-Mexico border". Int. J. Cancer, 2004, 109, 112.
48. Moberg M., Gustavsson I., Gyllensten U.: "Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ". Int. J. Cancer, 2004, 112, 854.
49. Hernandez-Hernandez D.M., Ornelas-Bernal L., Guido-Jimenez M., Apresa-Garcia T., Alvarado-Cabrero I., Salcedo-Vargas M. et al.: "Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women". Gynecol. Oncol., 2003, 90, 310.
50. Syrjänen K.: "Natural history of cervical HPV infections and CIN". In: Syrjänen K. and Syrjänen S. (eds.): "Papillomavirus Infections in Human Pathology". New York, J. Wiley & Sons, 2000, 142.
51. Gravitt P.E., Burk R.D., Lorincz A., Herrero R., Hildesheim A., Sherman M.E. et al.: "A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation". Cancer Epidemiol. Biomarkers Prev., 2003, 12, 477.
52. Pretet J.L., Dalstein V., Monnier-Benoit S., Delpeut S., Mougin C.: "High risk HPV load estimated by Hybrid Capture II((R)) correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women". J. Clin. Virol., 2004, 31, 140.
53. Peitsaro P., Johansson B., Syrjänen S.: "Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique". J. Clin. Microbiol., 2002, 40, 886.
54. Kulmala S.M., Syrjänen S.M., Gyllensten U.B., Shabalova I.E., Petrovichev N., Tosi P. et al.: "Early integration of high-copy HPV 16 detectable in women with normal and low-grade cervical cytology and histology". J. Clin. Pathol., 2005, in press.